MY116425A - Process for the protection of a person against contamination as a result of improper, i.e. oral, application of toxic components of a transdermal therapeutic system, as well as transdermal therapeuticsystems containing a denaturant - Google Patents

Process for the protection of a person against contamination as a result of improper, i.e. oral, application of toxic components of a transdermal therapeutic system, as well as transdermal therapeuticsystems containing a denaturant

Info

Publication number
MY116425A
MY116425A MYPI98004449A MYPI9804449A MY116425A MY 116425 A MY116425 A MY 116425A MY PI98004449 A MYPI98004449 A MY PI98004449A MY PI9804449 A MYPI9804449 A MY PI9804449A MY 116425 A MY116425 A MY 116425A
Authority
MY
Malaysia
Prior art keywords
transdermal
improper
oral
application
denaturant
Prior art date
Application number
MYPI98004449A
Inventor
Frank Becher
Ann-Katrin Klink
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of MY116425A publication Critical patent/MY116425A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Radiation-Therapy Devices (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROCESS FOR THE PROTECTION OF A PERSON AGAINST CONTAMINATION AS A RESULT OF IMPROPER, I.E. ORAL, APPLICATION OF TOXIC COMPONENTS OF A TRANSDERMAL THERAPEUTIC SYSTEM, AS WELL AS TRANSDERMAL THERAPEUTIC SYSTEMS CONTAINING A DENATURANT. DENATURANTS ARE ADDED TO A TRANSDERMAL THERAPEUTIC SYSTEM TO PREVENT AN IMPROPER, I.E. ORAL, APPLICATION.
MYPI98004449A 1997-10-01 1998-09-29 Process for the protection of a person against contamination as a result of improper, i.e. oral, application of toxic components of a transdermal therapeutic system, as well as transdermal therapeuticsystems containing a denaturant MY116425A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19743484A DE19743484C1 (en) 1997-10-01 1997-10-01 Transdermal patches containing substance with unpleasant taste

Publications (1)

Publication Number Publication Date
MY116425A true MY116425A (en) 2004-01-31

Family

ID=7844345

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI98004449A MY116425A (en) 1997-10-01 1998-09-29 Process for the protection of a person against contamination as a result of improper, i.e. oral, application of toxic components of a transdermal therapeutic system, as well as transdermal therapeuticsystems containing a denaturant

Country Status (23)

Country Link
EP (1) EP1019032B1 (en)
JP (2) JP4755338B2 (en)
KR (1) KR100552102B1 (en)
AT (1) ATE228356T1 (en)
AU (1) AU759609B2 (en)
CA (1) CA2305432C (en)
DE (2) DE19743484C1 (en)
DK (1) DK1019032T3 (en)
ES (1) ES2188021T3 (en)
HK (1) HK1029919A1 (en)
HU (1) HU226644B1 (en)
ID (1) ID24333A (en)
IL (1) IL134479A (en)
MY (1) MY116425A (en)
NO (2) NO319163B1 (en)
NZ (1) NZ503643A (en)
PL (1) PL193066B1 (en)
PT (1) PT1019032E (en)
SK (1) SK3332000A3 (en)
TR (1) TR200000461T2 (en)
TW (1) TW431894B (en)
WO (1) WO1999016428A1 (en)
ZA (1) ZA988904B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19743484C1 (en) * 1997-10-01 1999-01-28 Lohmann Therapie Syst Lts Transdermal patches containing substance with unpleasant taste
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US7867511B2 (en) * 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
DE102004019916A1 (en) * 2004-04-21 2005-11-17 Grünenthal GmbH Anti-abuse drug-containing patch
CN112823191A (en) * 2018-10-17 2021-05-18 日荣新化株式会社 Adhesive sheet and method for producing same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
DE4342174C1 (en) * 1993-12-10 1995-05-11 Lohmann Therapie Syst Lts Transdermal therapeutic system and a method for producing a transdermal therapeutic system for the combined transdermal application of physostigmine and scopolamine for the prophylaxis and pretreatment of poisoning by highly toxic organophosphorus neurotoxins, in particular Soman and its use
DE19743484C1 (en) * 1997-10-01 1999-01-28 Lohmann Therapie Syst Lts Transdermal patches containing substance with unpleasant taste

Also Published As

Publication number Publication date
EP1019032B1 (en) 2002-11-27
NO20001691L (en) 2000-03-31
AU759609B2 (en) 2003-04-17
JP2001517695A (en) 2001-10-09
ATE228356T1 (en) 2002-12-15
PL339736A1 (en) 2001-01-02
HUP0003476A3 (en) 2001-04-28
ID24333A (en) 2000-07-13
HU226644B1 (en) 2009-05-28
ES2188021T3 (en) 2003-06-16
NO20001492D0 (en) 2000-03-22
TW431894B (en) 2001-05-01
CA2305432C (en) 2007-04-03
KR20010030886A (en) 2001-04-16
SK3332000A3 (en) 2000-11-07
HK1029919A1 (en) 2001-04-20
TR200000461T2 (en) 2000-09-21
PL193066B1 (en) 2007-01-31
NO319163B1 (en) 2005-06-27
HUP0003476A2 (en) 2001-02-28
PT1019032E (en) 2003-04-30
DE59806468D1 (en) 2003-01-09
NO20001691D0 (en) 2000-03-31
CA2305432A1 (en) 1999-04-08
DE19743484C1 (en) 1999-01-28
NO20001492L (en) 2000-03-22
WO1999016428A1 (en) 1999-04-08
IL134479A (en) 2005-07-25
AU9626598A (en) 1999-04-23
IL134479A0 (en) 2001-04-30
DK1019032T3 (en) 2003-03-10
JP4755338B2 (en) 2011-08-24
ZA988904B (en) 1999-04-12
NZ503643A (en) 2003-05-30
JP2009035561A (en) 2009-02-19
KR100552102B1 (en) 2006-02-13
EP1019032A1 (en) 2000-07-19

Similar Documents

Publication Publication Date Title
MX9700082A (en) Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide.
IL114294A0 (en) Sterol derivatives
AU5906398A (en) Dosage composition for nasal delivery and method of use of the same
NZ331189A (en) Method of detection of influenza virus using neuraminidase binders
HUP9801626A3 (en) Pharmaceutical composition containing proton pump inhibitors
EP0935415A4 (en) Methods for delivering compounds into a cell
SE9704546D0 (en) Novel compounds
MX9602683A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutically active substances.
BG101131A (en) 2-oxo-and 2-thio-1,2-dihydroquinolinyl-oxazolidinons
AU6783698A (en) Polyaromatic antiviral compositions
GT199700009A (en) COMBINED THERAPY FOR OSTEOPOROSIS.
ATE231872T1 (en) THIAZOLOPYRIMIDE DERIVATIVES
NO984290L (en) Pharmaceutically useful compounds
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
TR199901584T1 (en) Granules containing clavulanate and one or more additional ingredients
DE69836678D1 (en) CHINOLIN AND CHINAZOLINE DERIVATIVES AS ANTAGONISTS OF THE CORTICOTROPIN RELEASING FACTOR (CRF)
MY116425A (en) Process for the protection of a person against contamination as a result of improper, i.e. oral, application of toxic components of a transdermal therapeutic system, as well as transdermal therapeuticsystems containing a denaturant
NZ308516A (en) Transdermal therapeutic system (tts) for administering testosterone
GB9907571D0 (en) Compounds
MX9709453A (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form.
ES2170377T3 (en) COMPOSITION CONTAINING QUITOSANA.
AP2000001746A0 (en) Anti- first-pass effect compounds.
UA32583C2 (en) Derivatives of arylthioalkylthiopyridine
IL136225A0 (en) Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation